Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches



David, CAW ORCID: 0000-0001-8504-2354, Owen, A ORCID: 0000-0002-9819-7651 and Liptrott, NJ ORCID: 0000-0002-5980-8966
(2016) Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches. NANOMEDICINE, 11 (11). pp. 1447-1464.

[img] Text
Review for nanomedicine_DAVID_OWEN_LIPTROTT.pdf - Author Accepted Manuscript

Download (911kB)

Abstract

The growing wealth of information regarding the influence that physicochemical characteristics play on nanoparticle biocompatibility and safety is allowing improved design and rationale for their development and preclinical assessment. Accurate and appropriate measurement of these characteristics accompanied by informed toxicological assessment is a necessity for the development of safe and effective nanomedicines. While particle type, formulation and mode of administration dictate the individual causes for concern through development, the benefits of nanoformulation for treatment of the diseased state are great. Here we have proposed certain considerations and suggestions, which could lead to better-informed preclinical assessment of nanomaterials for nanomedicine, as well as how this information can and should be extrapolated to the physiological state of the end user.

Item Type: Article
Uncontrolled Keywords: nanomedicine, nanoparticles, nanotoxicology
Depositing User: Symplectic Admin
Date Deposited: 08 Aug 2016 09:50
Last Modified: 19 Jan 2023 07:32
DOI: 10.2217/nnm-2016-0017
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3002806